VarCov Co’s Astrana Health ASTH Stock Holding History

VarCov Co’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,002	Closed	-$744K	–	669
2025 Q4	$744K	Buy	+30,002	New	+$797K	0.29%	99

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

VarCov Co's ASTH Position: Q1 2026 in Review

VarCov Co sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 30,002 shares — an estimated $744K sold.

VarCov Co first reported a position in ASTH in Q4 2025 and held it in 1 quarter. The position peaked at $744K in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

VarCov Co reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 30,002 Astrana Health shares in Q1 2026, an estimated $744K.
VarCov Co first reported a position in Astrana Health in Q4 2025 and held it in 1 quarter.
VarCov Co's Astrana Health position peaked at $744K in Q4 2025.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.